| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.009 |